Schonfeld Strategic Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,900
Closed -$35.3K 2464
2023
Q1
$35.3K Sell
13,900
-8,000
-37% -$20.3K ﹤0.01% 1738
2022
Q4
$41K Sell
21,900
-19,400
-47% -$36.3K ﹤0.01% 2230
2022
Q3
$106K Buy
41,300
+25,200
+157% +$64.7K ﹤0.01% 2477
2022
Q2
$31K Sell
16,100
-153,700
-91% -$296K ﹤0.01% 2191
2022
Q1
$504K Buy
+169,800
New +$504K ﹤0.01% 1306
2018
Q4
Sell
-85,000
Closed -$825K 1262
2018
Q3
$825K Sell
85,000
-100
-0.1% -$971 0.04% 469
2018
Q2
$868K Buy
85,100
+10,100
+13% +$103K 0.05% 415
2018
Q1
$975K Sell
75,000
-27,574
-27% -$358K 0.07% 324
2017
Q4
$1.84M Sell
102,574
-21,314
-17% -$382K 0.15% 189
2017
Q3
$3.11M Sell
123,888
-21,112
-15% -$530K 0.28% 113
2017
Q2
$3.5M Buy
145,000
+75,017
+107% +$1.81M 0.36% 67
2017
Q1
$1.35M Buy
+69,983
New +$1.35M 0.14% 217